|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0026882,
umls-concept:C0035820,
umls-concept:C0079419,
umls-concept:C0080103,
umls-concept:C0111429,
umls-concept:C0185117,
umls-concept:C0206754,
umls-concept:C0220901,
umls-concept:C0521447,
umls-concept:C0598086,
umls-concept:C0598388,
umls-concept:C1415887,
umls-concept:C1419040,
umls-concept:C1420433,
umls-concept:C1424666,
umls-concept:C1517945,
umls-concept:C2911684
|
|
pubmed:issue |
22
|
|
pubmed:dateCreated |
2008-11-17
|
|
pubmed:abstractText |
Gastroenteropancreatic neuroendocrine tumors (GEP-NET) are classified by the WHO, yet its prognostic value needs to be confirmed. Therefore, we aimed to determine the prognostic role of cell cycle key regulatory genes p53, p27kip1 (p27), and cyclin E in this tumor entity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
pubmed-author:ArnoldChristian NCN,
pubmed-author:ArnoldRudolfR,
pubmed-author:DanielPeter TPT,
pubmed-author:GeorgievaInnaI,
pubmed-author:GrabowskiPatriciaP,
pubmed-author:HörschDieterD,
pubmed-author:SchraderJörgJ,
pubmed-author:SteinHaraldH,
pubmed-author:SturmIsridI,
pubmed-author:WagnerJuliaJ,
pubmed-author:ZeitzMartinM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7378-84
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19010853-Adolescent,
pubmed-meshheading:19010853-Adult,
pubmed-meshheading:19010853-Aged,
pubmed-meshheading:19010853-Aged, 80 and over,
pubmed-meshheading:19010853-Animals,
pubmed-meshheading:19010853-Blotting, Western,
pubmed-meshheading:19010853-Cell Nucleus,
pubmed-meshheading:19010853-Cyclin E,
pubmed-meshheading:19010853-Cyclin-Dependent Kinase Inhibitor p27,
pubmed-meshheading:19010853-Digestive System Neoplasms,
pubmed-meshheading:19010853-Female,
pubmed-meshheading:19010853-Humans,
pubmed-meshheading:19010853-Immunohistochemistry,
pubmed-meshheading:19010853-Kaplan-Meier Estimate,
pubmed-meshheading:19010853-Male,
pubmed-meshheading:19010853-Middle Aged,
pubmed-meshheading:19010853-Mutation,
pubmed-meshheading:19010853-Neuroendocrine Tumors,
pubmed-meshheading:19010853-Oncogene Proteins,
pubmed-meshheading:19010853-Polymerase Chain Reaction,
pubmed-meshheading:19010853-Polymorphism, Single-Stranded Conformational,
pubmed-meshheading:19010853-Prognosis,
pubmed-meshheading:19010853-Rats,
pubmed-meshheading:19010853-Tumor Markers, Biological,
pubmed-meshheading:19010853-Tumor Suppressor Protein p53
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Loss of nuclear p27 expression and its prognostic role in relation to cyclin E and p53 mutation in gastroenteropancreatic neuroendocrine tumors.
|
|
pubmed:affiliation |
Medizinische Klinik I, Gastroenterologie/Infektiologie/Rheumatologie, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. patricia.grabowski@charite.de
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
